Supernus Pharmaceuticals (SUPN) said it will report third-quarter 2026 financial and business results after the market closes on October 29, 2026.
President and CEO Jack Khattar and Senior Vice President and CFO Tim Dec will host a conference call and webcast at 4:30 p.m. ET that day.
- Results release date: Thursday, October 29, 2026, after market close.
- Conference call and webcast: 4:30 p.m. ET on October 29, 2026.
- Live webcast: Supernus investor relations website.
- A replay will be available on the company’s investor relations website for 60 days following the call.
$SUPN Hedge Fund Activity
We have seen 153 institutional investors add shares of $SUPN stock to their portfolio, and 147 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. removed 1,318,555 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $61,325,993
- TWO SIGMA INVESTMENTS, LP added 913,150 shares (+336.7%) to their portfolio in Q2 2026, for an estimated $42,470,606
- ARMISTICE CAPITAL, LLC added 750,854 shares (+39.6%) to their portfolio in Q2 2026, for an estimated $34,922,219
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 703,552 shares (+inf%) to their portfolio in Q2 2026, for an estimated $32,722,203
- BLACKROCK, INC. added 552,792 shares (+6.3%) to their portfolio in Q2 2026, for an estimated $25,710,355
- MILLENNIUM MANAGEMENT LLC added 537,239 shares (+16.2%) to their portfolio in Q2 2026, for an estimated $24,986,985
- SOLEUS CAPITAL MANAGEMENT, L.P. added 520,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $24,185,200
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
